Patogeneza i leczenie nadciśnienia tętniczego u hemodializowanych chorych z przewlekłą chorobą nerek

Hypertension is frequently diagnosed among patients with chronic kidney disease (CKD) and often remains poorly controlled in end stage kidney disease (ESKD) especially in haemodialysis patients. These patients are characterized by higher blood pressure variability than the general population. Volume overload is a primary factor contributing into the pathogenesis of hypertension in this cohort. In the diagnosis and monitoring of hypertension in haemodialysis patients with chronic kidney disease self-measured of blood pressure at home done during the days between haemodialysis sessions should be considered. Home blood pressure measurements are of greater prognostic value than haemodialysis unit recording. Target-values of blood pressure in haemodialysis patients are still matter of debate. However, self-measured systolic blood pressure values at home between 120 to 130 mmHg are associated with the best prognosis in haemodialysis patients with CKD. Among not pharmacological methods of antihypertensive treatment in haemodialysis patients with CKD reducing volaemia by increasing ultrafiltration during haemodialysis procedures, individualization of sodium concentration in the dialysis fluid and low sodium diet should be listed. While, in the pharmacotherapy b-adrenergic antagonists seem to be the drugs of first choice

Arterial Hypertension 2017;21(4):195-204.

PEŁNA TREŚĆ ARTYKUŁU:

www.journals.viamedica.pl/arterial_hypertension